FDA.reportPublic FDA data

Zafemy 150/35 MCG/Day Weekly Transdermal System

RxCUI
2531285
RxNorm name
Zafemy 150/35 MCG/Day Weekly Transdermal System
Display name
Zafemy 150/35 MCG/Day Weekly Transdermal System
Full name
Zafemy 150/35 MCG/Day Weekly Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZAFEMYNORELGESTROMIN AND ETHINYL ESTRADIOLAvKAREfbbd12dd-c538-2869-e053-6294a90a1a382026-01-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2531285
ZAFEMYNORELGESTROMIN AND ETHINYL ESTRADIOLBryant Ranch Prepack77230a20-4269-4abf-ae2a-ac5ccafef5652024-01-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2531285
ZAFEMYNORELGESTROMIN AND ETHINYL ESTRADIOLAmneal Pharmaceuticals LLC5ee34c07-65af-42b8-a98f-e299ff90a8a12022-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2531285

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
77230a20-4269-4abf-ae2a-ac5ccafef565ZAFEMY 150/35 MCG/Day Weekly Transdermal System [PSN] · 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Zafemy] [SBD] · Zafemy 150/35 MCG/Day Weekly Transdermal System [SY]3100These highlights do not include all the information needed to use ZAFEMY safely and effectively. See full prescribing information for ZAFEMY . ZAFEMY ® (norelgestromin and ethinyl estradiol transdermal system) Initial U.S. Approval: 200120240105
5ee34c07-65af-42b8-a98f-e299ff90a8a1ZAFEMY 150/35 MCG/Day Weekly Transdermal System [PSN] · 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Zafemy] [SBD] · Zafemy 150/35 MCG/Day Weekly Transdermal System [SY]37These highlights do not include all the information needed to use ZAFEMY safely and effectively. See full prescribing information for ZAFEMY . ZAFEMY ® (norelgestromin and ethinyl estradiol transdermal system) Initial U.S. Approval: 200120220430
fbbd12dd-c538-2869-e053-6294a90a1a38ZAFEMY 150/35 MCG/Day Weekly Transdermal System [PSN] · 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Zafemy] [SBD] · Zafemy 150/35 MCG/Day Weekly Transdermal System [SY]32ZAFEMY ® (norelgestromin and ethinyl estradiol transdermal system) These highlights do not include all the information needed to use ZAFEMY safely and effectively. See full prescribing information for ZAFEMY . ZAFEMY ® (norelgestromin and ethinyl estradiol transdermal system) Initial U.S. Approval: 200120260119